
Sign up to save your podcasts
Or


In this episode, Omar Khateeb, Founder of Marketcraft, shares a focused breakdown of how MedTech companies build toward strong exits. Based on $17B in acquisition insights, this solo episode reframes exits as outcomes of deliberate strategy, not last-minute negotiations. Omar highlights how founders create leverage through early acquirer relationships, clear category positioning, and sustained market presence. He also explains why competitive tension matters, how timing impacts value, and why clinical clarity plays a central role in decision-making. If you want a sharper understanding of how MedTech exits actually happen, this episode gives you a clear and actionable perspective.
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.
Episode Breakdown:
00:00 Why Most MedTech Exits Fail (No One Finds You)
00:59 Intro + $17B in Exit Lessons Explained
02:30 Lesson 1: Acquirer Relationships Take Years
05:30 Why Visibility and Narrative Matter
08:00 Lesson 2: The Power of Not Needing to Sell
10:30 Why 85% of Deals Have Only One Buyer
12:44 Market Problem vs Product Problem
14:18 Strategic Investors Can Reduce Leverage
16:30 Lesson 3: Hard Endpoints vs Surrogate Metrics
19:30 Why Clinical Data Drives Acquisitions
21:53 Lesson 4: Investigators as Strategic Assets
24:30 Why Skeptics Are More Valuable Than Believers
27:00 Lesson 5: Acquirer Culture Matters More Than Price
30:00 Post-Acquisition Success vs Deal Size
31:30 Lesson 6: Phase 2 Data = Maximum Leverage
34:00 Timing Your Exit for Maximum Value
35:30 Lesson 7: CEO Resilience Drives Exit Outcomes
37:12 Final Thoughts + Founder Mindset
37:49 Outro
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omar.m.khateebX https: https://x.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb
#medtech #mergersandacquisitions #startupstrategy #venturecapital #healthcareinnovation
By State of MedtechIn this episode, Omar Khateeb, Founder of Marketcraft, shares a focused breakdown of how MedTech companies build toward strong exits. Based on $17B in acquisition insights, this solo episode reframes exits as outcomes of deliberate strategy, not last-minute negotiations. Omar highlights how founders create leverage through early acquirer relationships, clear category positioning, and sustained market presence. He also explains why competitive tension matters, how timing impacts value, and why clinical clarity plays a central role in decision-making. If you want a sharper understanding of how MedTech exits actually happen, this episode gives you a clear and actionable perspective.
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.
Episode Breakdown:
00:00 Why Most MedTech Exits Fail (No One Finds You)
00:59 Intro + $17B in Exit Lessons Explained
02:30 Lesson 1: Acquirer Relationships Take Years
05:30 Why Visibility and Narrative Matter
08:00 Lesson 2: The Power of Not Needing to Sell
10:30 Why 85% of Deals Have Only One Buyer
12:44 Market Problem vs Product Problem
14:18 Strategic Investors Can Reduce Leverage
16:30 Lesson 3: Hard Endpoints vs Surrogate Metrics
19:30 Why Clinical Data Drives Acquisitions
21:53 Lesson 4: Investigators as Strategic Assets
24:30 Why Skeptics Are More Valuable Than Believers
27:00 Lesson 5: Acquirer Culture Matters More Than Price
30:00 Post-Acquisition Success vs Deal Size
31:30 Lesson 6: Phase 2 Data = Maximum Leverage
34:00 Timing Your Exit for Maximum Value
35:30 Lesson 7: CEO Resilience Drives Exit Outcomes
37:12 Final Thoughts + Founder Mindset
37:49 Outro
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omar.m.khateebX https: https://x.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb
#medtech #mergersandacquisitions #startupstrategy #venturecapital #healthcareinnovation